There have been 50 recent insider transactions recorded for Brainstorm Cell Therapeutics Inc. (BCLI), including 44 buys and 1 sell. Total insider buying was valued at $575.32K and total insider selling at $22.07K.
Notable insiders with recent activity include Hartounian Hartoun, Frenkel Jacob A, Arbel Irit. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — BCLI
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-01-01 |
Hartounian Hartoun |
EVP, Chief Operating Officer |
RSU Award |
50,000 |
- |
- |
52,000 |
| 2025-01-01 |
Frenkel Jacob A |
Director |
RSU Award |
40,000 |
- |
- |
43,777 |
| 2025-01-01 |
Arbel Irit |
Director |
RSU Award |
30,666 |
- |
- |
41,054 |
| 2025-01-01 |
Lebovits Chaim |
President & CEO |
RSU Award |
120,000 |
- |
- |
200,960 |
| 2025-01-01 |
Yablonka Uri |
EVP & Chief Business Officer |
RSU Award |
40,000 |
- |
- |
48,464 |
| 2025-01-01 |
Patlis Alla |
See Remarks |
RSU Award |
40,000 |
- |
- |
44,349 |
| 2025-01-01 |
Polverino Anthony J. |
Director |
RSU Award |
24,000 |
- |
- |
25,730 |
| 2025-01-01 |
Lindborg Stacy |
Director |
RSU Award |
20,000 |
- |
- |
48,229 |
| 2025-01-01 |
Bairu Menghisteab |
Director |
RSU Award |
24,000 |
- |
- |
24,000 |
| 2025-01-01 |
Naor Nir |
Director |
RSU Award |
30,666 |
- |
- |
31,465 |
| 2025-01-01 |
Dagher Ibrahim B. |
Chief Medical Officer |
RSU Award |
50,000 |
- |
- |
66,849 |
| 2024-10-01 |
Lebovits Chaim |
President & CEO |
Informative Buy |
1,836 |
$3.43 |
$6.29K |
80,960 |
| 2024-09-30 |
Lebovits Chaim |
President & CEO |
Informative Buy |
22,000 |
$0.23 |
$5.02K |
1,186,865 |
| 2024-07-19 |
Dagher Ibrahim B. |
Chief Medical Officer |
Informative Sell |
63,000 |
$0.35 |
$22.07K |
- |
| 2024-06-24 |
Hartounian Hartoun |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-06-24 |
Hartounian Hartoun |
EVP, Chief Operating Officer |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2024-05-28 |
Lebovits Chaim |
President & CEO |
RSU Award |
15,000 |
$0.52 |
$7.77K |
1,164,865 |
| 2024-05-28 |
Lebovits Chaim |
President & CEO |
Informative Buy |
15,000 |
$0.52 |
$7.77K |
1,164,865 |
| 2024-05-22 |
Lebovits Chaim |
President & CEO |
RSU Award |
25,000 |
$0.64 |
$16K |
1,149,865 |
| 2024-05-22 |
Lebovits Chaim |
President & CEO |
Informative Buy |
25,000 |
$0.64 |
$16K |
1,149,865 |
| 2024-05-21 |
Lebovits Chaim |
President & CEO |
RSU Award |
25,000 |
$0.58 |
$14.48K |
1,124,865 |
| 2024-05-21 |
Lebovits Chaim |
President & CEO |
Informative Buy |
25,000 |
$0.58 |
$14.48K |
1,124,865 |
| 2024-05-13 |
Lebovits Chaim |
President & CEO |
RSU Award |
10,000 |
$0.49 |
$4.9K |
1,099,865 |
| 2024-05-13 |
Lebovits Chaim |
President & CEO |
Informative Buy |
10,000 |
$0.49 |
$4.9K |
1,099,865 |
| 2024-05-11 |
Lebovits Chaim |
President & CEO |
RSU Award |
10,000 |
$0.47 |
$4.67K |
1,089,865 |
| 2024-05-11 |
Lebovits Chaim |
President & CEO |
Informative Buy |
10,000 |
$0.47 |
$4.67K |
1,089,865 |
| 2024-05-10 |
Lebovits Chaim |
President & CEO |
RSU Award |
20,000 |
$0.47 |
$9.3K |
1,079,865 |
| 2024-05-10 |
Lebovits Chaim |
President & CEO |
Informative Buy |
20,000 |
$0.47 |
$9.3K |
1,079,865 |
| 2024-05-07 |
Lebovits Chaim |
President & CEO |
RSU Award |
66,300 |
$0.37 |
$24.82K |
1,059,865 |
| 2024-05-07 |
Lebovits Chaim |
President & CEO |
Informative Buy |
66,300 |
$0.37 |
$24.82K |
1,059,865 |
| 2024-05-06 |
Lebovits Chaim |
President & CEO |
RSU Award |
135,000 |
$0.38 |
$50.67K |
993,565 |
| 2024-05-06 |
Lebovits Chaim |
President & CEO |
Informative Buy |
135,000 |
$0.38 |
$50.67K |
993,565 |
| 2024-04-19 |
Lebovits Chaim |
President & CEO |
RSU Award |
15,000 |
$0.52 |
$7.8K |
858,565 |
| 2024-04-19 |
Lebovits Chaim |
President & CEO |
Informative Buy |
15,000 |
$0.52 |
$7.8K |
858,565 |
| 2024-04-18 |
Lebovits Chaim |
President & CEO |
RSU Award |
115,072 |
$0.53 |
$60.47K |
843,565 |
| 2024-04-18 |
Lebovits Chaim |
President & CEO |
Informative Buy |
115,072 |
$0.53 |
$60.47K |
843,565 |
| 2024-04-17 |
Dagher Ibrahim B. |
Chief Medical Officer |
Unknown |
80,000 |
$1.73 |
$138.4K |
- |
| 2024-04-17 |
Lebovits Chaim |
President & CEO |
RSU Award |
130,000 |
$0.55 |
$70.94K |
728,493 |
| 2024-04-17 |
Dagher Ibrahim B. |
Chief Medical Officer |
Unknown |
- |
- |
- |
30,000 |
| 2024-04-17 |
Lebovits Chaim |
President & CEO |
Informative Buy |
130,000 |
$0.55 |
$70.94K |
728,493 |
| 2024-03-11 |
Lebovits Chaim |
President & CEO |
RSU Award |
305,198 |
- |
- |
598,493 |
| 2024-03-11 |
Yablonka Uri |
EVP & Chief Business Officer |
RSU Award |
109,426 |
- |
- |
126,969 |
| 2024-03-11 |
Patlis Alla |
See Remarks |
RSU Award |
65,246 |
- |
- |
65,246 |
| 2024-03-11 |
Lindborg Stacy |
Co-chief Executive Officer |
RSU Award |
241,935 |
- |
- |
423,435 |
| 2023-09-01 |
Lindborg Stacy |
Co-chief Executive Officer |
Informative Buy |
11,500 |
$1.77 |
$20.4K |
181,500 |
| 2023-08-02 |
Lebovits Chaim |
President & CEO |
RSU Award |
31,185 |
- |
- |
293,295 |
| 2023-08-02 |
Lindborg Stacy |
Co-chief Executive Officer |
RSU Award |
35,000 |
- |
- |
170,000 |
| 2023-06-19 |
Naor Nir |
Director |
Unknown |
- |
- |
- |
- |
| 2023-06-19 |
Naor Nir |
Director |
RSU Award |
11,999 |
- |
- |
11,999 |
| 2023-05-01 |
Taylor Kirk |
Officer |
Unknown |
- |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
